115 related articles for article (PubMed ID: 36686566)
1. Impact of drug interactions with direct oral anticoagulants on mortality in elderly with atrial fibrillation during the COVID-19 pandemic.
Ersoy İ; Ersoy P
Med Clin (Engl Ed); 2023 Jan; 160(2):71-77. PubMed ID: 36686566
[TBL] [Abstract][Full Text] [Related]
2. Impact of drug interactions with direct oral anticoagulants on mortality in elderly with atrial fibrillation during the COVID-19 pandemic.
Ersoy İ; Ersoy P
Med Clin (Barc); 2023 Jan; 160(2):71-77. PubMed ID: 35931571
[TBL] [Abstract][Full Text] [Related]
3. Novel Drug Interaction index and Risk of Mortality in Older Patients With Atrial Fibrillation Receiving Non Vitamin K Oral Anticoagulants (NOEL Drug).
Ersoy İ
Clin Appl Thromb Hemost; 2021; 27():10760296211038685. PubMed ID: 34541922
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
5. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
[TBL] [Abstract][Full Text] [Related]
6. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
[TBL] [Abstract][Full Text] [Related]
7. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
[TBL] [Abstract][Full Text] [Related]
8. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists.
Sakai T; Motoki H; Fuchida A; Takeuchi T; Otagiri K; Kanai M; Kimura K; Minamisawa M; Yoshie K; Saigusa T; Ebisawa S; Okada A; Kitabayashi H; Kuwahara K
Heart Vessels; 2022 Jul; 37(7):1232-1241. PubMed ID: 35064298
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Jackson LR; Kim S; Blanco R; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Kowey PR; Mahaffey KW; Hylek EM; Peterson ED; Piccini JP;
Am Heart J; 2020 Aug; 226():85-93. PubMed ID: 32526533
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin-naïve or warfarin-experienced patients.
Perino AC; Fan J; Pundi K; Schmitt S; Kothari M; Din N; Heidenreich PA; Turakhia MP
Clin Cardiol; 2022 Sep; 45(9):960-969. PubMed ID: 35946047
[TBL] [Abstract][Full Text] [Related]
14. The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation.
van den Dries CJ; van Doorn S; Souverein P; Pajouheshnia R; Moons KGM; Hoes AW; Geersing GJ; van den Ham HA
TH Open; 2020 Oct; 4(4):e417-e426. PubMed ID: 33376941
[No Abstract] [Full Text] [Related]
15. Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.
Lutsey PL; Norby FL; Ensrud KE; MacLehose RF; Diem SJ; Chen LY; Alonso A
JAMA Intern Med; 2020 Feb; 180(2):245-253. PubMed ID: 31764956
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
[TBL] [Abstract][Full Text] [Related]
17. Direct oral anticoagulants and the risk of osteoporotic fractures in patients with non-valvular atrial fibrillation.
Kuo LT; Lin SJ; Wu VC; Chang JJ; Chu PH; Lin YS
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211011374. PubMed ID: 33995605
[TBL] [Abstract][Full Text] [Related]
18. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
19. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
Blomström Lundqvist C; Själander S; Garcia Rodriguez LA; Åkerborg Ö; Jin G; Caleyachetty A; Huelsebeck M; Bowrin K; Schaefer B; Mahdessian H; Hofmeister L; Levin LÅ
J Med Econ; 2022; 25(1):1085-1091. PubMed ID: 35997241
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study.
Admassie E; Chalmers L; Bereznicki LR
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):329-336. PubMed ID: 29642709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
